Navigation Links
New MS drug proves effective where others have failed
Date:10/31/2012

long-term clinical improvements," said Professor Alastair Compston from the University of Cambridge, principal investigator on both studies and Chair of the Steering Committee which oversaw these and earlier clinical trials.

For the study (CARE MS II), researchers recruited 840 MS patients (of whom 628 were used for the principal analysis) who had been treated previously but had recently relapsed during their therapy. They were divided in a ratio of 2:1 to receive either alemtuzumab or interferon beta-1a. Their disability was then assessed every three months for two years by a researcher who was not made aware of which drug the patient had received. Additionally, they had annual scans to assess the lesions and brain shrinkage caused by MS.

Alemtuzumab was found significantly to reduce the risk of having another relapse of MS or becoming disabled over the next two years, compared to one of the most effective licensed therapies for similar cases of MS, interferon beta-1a. Additionally, most patients on alemtuzumab experienced an improvement in disability, which was not seen after treatment with interferon-beta 1a. The brain scans showed that alemtuzumab not only reduced the number of new lesions, compared to interferon beta-1a, but also reduced the rate of brain shrinkage that occurs in MS as tissue is damaged.

"Although other MS drugs have emerged over the last year which is certainly good news for patients none has shown superior effects on disability when compared to interferon except alemtuzumab. Additionally, no other treatment has led to improvements in disability," said Dr Alasdair Coles, lead author of the paper and a clinician from the University of Cambridge.

MS is an autoimmune disease in which the body's immune system mistakenly attacks nerve fibres and their protective insulation, the myelin sheath, in the central nervous system. The resulting damage prevents the nerves from 'firing' properly and ultimately leads to the loss of th
'/>"/>

Contact: Genevieve Maul
Genevieve.maul@admin.cam.ac.uk
44-012-237-65542
University of Cambridge
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Clinical insight improves treatment with new lung cancer drug
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
4. Exercise improves quality of life during breast cancer treatment
5. Early treatment improves outcomes in rare, often undiagnosed form of encephalitis
6. NYUCNs Dr. Laura Wagner: Study finds accreditation improves safety culture at nursing homes
7. Cone beam CT proves better for visualizing some causes of hearing loss at half the radiation dose
8. Brief training program improves resident physicians empathy with patients
9. FDA Approves Generic Versions of Plavix
10. A nurse practitioner-driven palliative care intervention improves cancer patients quality of life
11. Oxytocin improves brain function in children with autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 04, 2015 As seen ... Endometriosis can be a painful condition in which ... outside of the uterus leading to very unpleasant symptoms ... Endometriosis can have a terrible effect on women’s quality ... also the most common cause of infertility in women ...
(Date:3/4/2015)... March 04, 2015 Organic Valley, the nation’s ... today announced its cause campaign to Save the Bros, ... is making a difference to Bros everywhere. To date, ... and Facebook. The video was named Adweek’s best commercial ... Forbes, Mashable and Digiday, among other media outlets. , ...
(Date:3/4/2015)... March 04, 2015 Information Innovators ... John Dvorak has joined the company as Chief ... the technology focus for the company, including customer-centric strategies ... brings 20 years of experience as a technology executive ... diverse roles at the FBI including oversight of enterprise ...
(Date:3/4/2015)... March 04, 2015 The Alliance ... leaders for its upcoming fifth annual Advanced Therapies ... France. The event this year will feature five ... 20 of the field’s leading companies and organizations. ... top executives and clinical researchers from the advanced ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 The ... WaterAid a total of $6.9 million, which will ... Mali, Niger and Burkina Faso. , The programs cover ... The first will focus on fixing water points in ... skills of local people to maintain water points and ...
Breaking Medicine News(10 mins):Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4
... enzyme found in the venom of the brown recluse spider, ... discovered a new way to open// molecular pores, called ion ... research team – Zhe Lu, MD, PhD; Yajamana Ramu, PhD; ... at Penn – screened venoms from over 100 poisonous invertebrate ...
... fiber and fruit each day is the key to maintaining ... of examining the diets of 52// normal-weight adults and 52 ... normal weight adults consumed 33 percent more dietary fiber and ... fiber and complex carbohydrates are associated with a lean mass ...
... reported a new outbreak of bird flu among poultry in ... ,The national avian influenza laboratory tested samples and confirmed the ... outbreak that began on July 14 near the town of ... 3,045 chickens died in the outbreak, and agriculture workers culled ...
... approval to an implantable contraceptive called Implanon. The matchstick sized ... and prevents pregnancy for three year after which it may ... said that the implant would release a low but steady ... countries since 1998 and an estimated 2.5 million women have ...
... broad-spectrum IV antibiotic that can be used for the ... caused by antibiotic// resistant bacteria such as methicillin-resistant Staphylococcus ... from today. Availability of this new antibiotic comes at ... is greater than ever and clinicians are running out ...
... hope to use gas bubbles like corks to block oxygen ... process of blocking blood flow to a tumor is called ... embolotherapy. What makes it so promising is that the technique ... so blockage of blood flow to surrounding tissue is minimal, ...
Cached Medicine News:Health News:New Way to Open Cellular Ion Channels, Implications for Drug Design 2Health News:Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria 2Health News:Researchers Use Bubbles in Cancer Treatment and Drug Delivery 2
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... products, today announced that Jeffrey H. Burbank , Chief ... Conference in Miami, FL on Wednesday, ... A webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... , March 4, 2015 The March 3, 2015, order ... drugs must change their products, labels to clarify the drugs, ... attack and stroke is necessary to protect the public from ... a partner at Simmons Hanly Conroy . ... labels that the products – currently taken by millions of ...
(Date:3/4/2015)... 4, 2015 UPM Pharmaceuticals, a division of ... Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets. Sprout ... the first drug approved to treat hypoactive sexual desire ... dysfunction. The tablets will be manufactured at ... Tennessee . Dr. John M. ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3
... the leading public medical equipment marketplace, and the leader ... has launched its Certified Parts Vendor (CPV) Program. ... parts vendors, provide enhanced vendor due diligence and create ... CPV Program is create stronger direct buyer-seller relationships. , ...
... 8 Endologix, Inc. (Nasdaq: ELGX ), developer of ... has become aware that Cook Medical has filed a lawsuit ... Endologix infringes two of Cook,s U.S. patents. , John McDermott, ... become aware of the lawsuit filed by Cook alleging that ...
Cached Medicine Technology:DOTmed Announces Certified Parts Vendor (CPV) Program 2Endologix Comments on Alleged Patent Infringement 2
... first fully automated blood ... North American market based ... Test™. The ORTHO ProVue™ ... while increasing productivity via ...
... people are in need of MRI exams, ... tunnel-type scanners. They have heard of, or ... claustrophobic and noisy tubes of supercon scanners ... What people want is a patient-friendly MRI. ...
Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance....
... The Gemini XPS ... high-sensitivity measurements as required ... fluorescence-based assays. Cellular and ... quantitation, drug screening, and ...
Medicine Products: